Tus-Pharmaceutical Group Co., Ltd. (000590.SZ)
CNY 7.98
(-0.25%)
CNY 7.98
(-0.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 395.92 Million | 350.52 Million | 300.77 Million | 275.09 Million | 315.03 Million | 185.81 Million |
| Cost of Revenue | 193.41 Million | 171.32 Million | 134.51 Million | 121.81 Million | 147.37 Million | 98.05 Million |
| Gross Profit | 202.51 Million | 179.2 Million | 166.25 Million | 153.27 Million | 167.66 Million | 87.75 Million |
| Operating Expenses | 191.95 Million | 163 Million | 132.16 Million | 130.87 Million | 139.91 Million | 123.52 Million |
| Selling, General and Administrative Expenses | 171.84 Million | 76.78 Million | 55.3 Million | 46.77 Million | 67.58 Million | 57.67 Million |
| Research and Development Expenses | 12.81 Million | 13.1 Million | 8.28 Million | 9.59 Million | 9.45 Million | 7.48 Million |
| Other Expenses | 1.86 Million | 73.12 Million | 68.56 Million | 74.5 Million | 62.86 Million | -621.51 Thousand |
| Cost and Expenses | 384.48 Million | 334.33 Million | 266.67 Million | 252.68 Million | 287.28 Million | 221.58 Million |
| Operating Income | 20.15 Million | 22.67 Million | 42.35 Million | 27.78 Million | 36.18 Million | -35.28 Million |
| Interest Expense | 4.46 Million | 1.15 Million | 471.69 Thousand | 13.32 Thousand | 1.64 Million | 1.49 Million |
| Income Tax Expense | 4.78 Million | 3.7 Million | 6.39 Million | 4.91 Million | 11 Million | 2.27 Million |
| Earnings before Tax | 29.67 Million | 21.87 Million | 41.83 Million | 27.64 Million | 53.44 Million | -35.9 Million |
| Net Income | 25.24 Million | 18.1 Million | 35.43 Million | 22.72 Million | 42.44 Million | -38.18 Million |
| Earnings Per Share Basic | 0.11 | 0.08 | 0.15 | 0.09 | 0.18 | -0.16 |
| Earnings Per Share Diluted | 0.11 | 0.08 | 0.15 | 0.09 | 0.18 | -0.16 |
| Weighted Average Shares Outstanding | 239.47 Million | 239.47 Million | 239.47 Million | 239.47 Million | 239.47 Million | 239.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 239.47 Million | 239.47 Million | 239.47 Million | 239.47 Million | 239.47 Million | 239.52 Million |
| Gross Margin | 0.51 | 0.51 | 0.55 | 0.56 | 0.53 | 0.47 |
| EBIT Margin | 0.16 | 0.13 | 0.21 | 0.16 | 0.16 | -0.06 |
| Profit Margin | 0.06 | 0.05 | 0.12 | 0.08 | 0.13 | -0.21 |
| EBITDA | 62.18 Million | 48.43 Million | 62.46 Million | 42.42 Million | 70.91 Million | -16.69 Million |
| Earnings Before Tax Margin | 0.05 | 0.06 | 0.14 | 0.10 | 0.11 | -0.19 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 69.57 Million | 69.55 Million | 75.27 Million | 127.54 Million | 395.92 Million | 84.57 Million |
| Cost of Revenue | 39.04 Million | 39.32 Million | 37.95 Million | 65.63 Million | 206.05 Million | 41.96 Million |
| Gross Profit | 30.53 Million | 30.23 Million | 37.32 Million | 61.9 Million | 189.87 Million | 42.61 Million |
| Operating Expenses | 35.05 Million | 41.76 Million | 45.34 Million | 69.74 Million | 183.77 Million | 41.99 Million |
| Selling, General and Administrative Expenses | 82.14 Million | 783.18 Thousand | 42.81 Million | 59.99 Million | - | 69.9 Million |
| Research and Development Expenses | 3.03 Million | 4.16 Million | 2.53 Million | 3.36 Million | - | 3.15 Million |
| Other Expenses | -50.12 Million | -607.26 Thousand | -48.25 Thousand | -6.38 Million | 115.99 Thousand | -12.2 Thousand |
| Cost and Expenses | 74.09 Million | 81.08 Million | 83.3 Million | 135.37 Million | 389.82 Million | 83.95 Million |
| Operating Income | -4.95 Million | -12.99 Million | -8.02 Million | -7.83 Million | 6.1 Million | 509.87 Thousand |
| Interest Expense | 914.56 Thousand | 968.83 Thousand | 952.71 Thousand | 966.26 Thousand | 4.46 Million | 1.06 Million |
| Income Tax Expense | -108.47 Thousand | 1.4 Million | 1.19 Million | 1.87 Million | 4.78 Million | 377.42 Thousand |
| Earnings before Tax | -5.06 Million | -13.6 Million | -7.06 Million | 20.18 Million | 29.67 Million | 497.66 Thousand |
| Net Income | -5.05 Million | -15.11 Million | -8.28 Million | 18.81 Million | 25.24 Million | 47.6 Thousand |
| Earnings Per Share Basic | -0.02 | -0.06 | -0.03 | 0.08 | - | 0.00 |
| Earnings Per Share Diluted | -0.02 | -0.06 | -0.03 | 0.08 | - | 0.00 |
| Weighted Average Shares Outstanding | 239.47 Million | 239.47 Million | 239.47 Million | 239.47 Million | 239.47 Million | 239.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 239.47 Million | 239.47 Million | 239.47 Million | 239.47 Million | 239.47 Million | 239.47 Million |
| Gross Margin | 0.44 | 0.43 | 0.50 | 0.49 | 0.48 | 0.50 |
| EBIT Margin | -0.06 | -0.17 | -0.08 | -0.01 | - | 0.02 |
| Profit Margin | -0.07 | -0.22 | -0.11 | 0.15 | 0.06 | 0.00 |
| EBITDA | -4.15 Million | -11.93 Million | -6.11 Million | -789.12 Thousand | - | 1.3 Million |
| Earnings Before Tax Margin | -0.07 | -0.19 | -0.11 | -0.06 | 0.02 | 0.01 |
MSBHF
THRD
600261
002176
ITE
WMLLF